Forbes April 26, 2024
When developing new therapies for diseases, biotech researchers are often limited by two time-consuming steps: first, screening thousands of drug candidates in test tubes and second, taking the best candidates and testing them on multiple animals to make sure it’s safe and effective. Combined, these steps can be slow and expensive.
Today, a startup called Gordian Biotechnology debuted a technology that could make this process better for both animals and people. The San Francisco-based company has developed a new animal screening platform which allows multiple gene therapies to be tested at the same time with just one animal. Instead of the gene treatment being given to the animal and affecting an entire area of its body, Gordian’s innovation enables it...
Today's Sponsors
Today's Sponsor